T2 Biosystems, Inc.
General ticker "TTOO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.7M (TTM average)
T2 Biosystems, Inc. does not follow the US Stock Market performance with the rate: -21.3%.
Estimated limits based on current volatility of 10.2%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 113 (-28.5%) as of 2023
- Top business risk factors: Manufacturing risks, Dependence on key products, Geopolitical risks, Operational and conduct risks, Market competition
- Current price 97.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.12$, 5.54$]
- 2024-12-30 to 2025-12-30 estimated range: [0.40$, 2.06$]
Financial Metrics affecting the TTOO estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -347.11 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -80.57 <= 18.93
- Positive: -4.48 < Investing cash flow per share per price, % of -1.38
- Negative: Inventory ratio change, % of 23.21 > 0.84
Short-term TTOO quotes
Long-term TTOO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $28.06MM | $22.30MM | $7.19MM |
| Operating Expenses | $71.03MM | $77.50MM | $56.86MM |
| Operating Income | $-42.97MM | $-55.20MM | $-49.66MM |
| Non-Operating Income | $-6.27MM | $-7.46MM | $-0.41MM |
| Interest Expense | $6.59MM | $6.08MM | $5.34MM |
| R&D Expense | $21.80MM | $25.77MM | $14.15MM |
| Income(Loss) | $-49.24MM | $-62.66MM | $-50.08MM |
| Profit(Loss)* | $-49.24MM | $-62.66MM | $-50.08MM |
| Stockholders Equity | $-12.90MM | $-39.66MM | $-28.04MM |
| Inventory | $3.91MM | $4.35MM | $4.82MM |
| Assets | $60.54MM | $34.33MM | $34.80MM |
| Operating Cash Flow | $-38.87MM | $-50.63MM | $-48.14MM |
| Capital expenditure | $0.46MM | $0.34MM | $0.19MM |
| Investing Cash Flow | $24.79MM | $9.66MM | $-0.19MM |
| Financing Cash Flow | $20.54MM | $29.05MM | $52.69MM |
| Earnings Per Share** | $-1,549.82 | $-1,228.46 | $-19.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.